Centiva Capital, LP Novartis Ag Transaction History
Centiva Capital, LP
- $4.65 Billion
- Q4 2024
A detailed history of Centiva Capital, LP transactions in Novartis Ag stock. As of the latest transaction made, Centiva Capital, LP holds 5,119 shares of NVS stock, worth $574,454. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,119
Previous 2,263
126.2%
Holding current value
$574,454
Previous $260,000
91.54%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$918 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$771 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$626 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...